Comera Life Sciences Holdings, Inc. (CMRA)
| Market Cap | 51.92M |
| Revenue (ttm) | 319,832 |
| Net Income (ttm) | -5.45M |
| Shares Out | 19.09M |
| EPS (ttm) | -6.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 343,128 |
| Open | 2.92 |
| Previous Close | 2.97 |
| Day's Range | 2.72 - 3.14 |
| 52-Week Range | 1.11 - 15.30 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CMRA
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Scien... [Read more...]
Financial Performance
In 2021, CMRA's revenue was $319,832, a decrease of -27.79% compared to the previous year's $442,919. Losses were -$5.45 million, 156.5% more than in 2020.
Financial StatementsNews
Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, sa...
3 Top Stocks To Watch Before Next Week
Penny stocks to watch right now. The post 3 Top Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, sa...
What's Going On With OTR Acquisition Stock Today?
OTR Acquisition Corp (NASDAQ: OTRA) shares are trading higher Wednesday after the company filed a Form 8-K with the U.S. Securities and Exchange Commision. The move appears to be related to the high num...
Why Is OTR Acquisition (OTRA) Stock Up Today?
The shares of OTR Acquisition are climbing after the SPAC's shareholders overwhelmingly approved a merger with Comera. The post Why Is OTR Acquisition (OTRA) Stock Up Today?
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Form...
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and c...
Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc., which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced ...
Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration
WOBURN, Mass. & AHMEDABAD, India--(BUSINESS WIRE)--Today, Comera Life Sciences, Inc. (“Comera” or the “Company”) and Intas Pharmaceuticals Ltd. (“Intas”) announced a research collaboration to develop a ...
Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business...
WOBURN, Mass. & MIAMI--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenienc...